Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
NCT05349630Phase 1Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Mar 2028
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ferrous sulfate in hypoxia and Right ventricular dysfunction (RVD) (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Maximum workload up to 1 hour and Maximal oxygen uptake up to 1 hour. Planned start Mar 2028; status: not yet recruiting.
02
Drugs
ferrous sulfate
03
Conditions
hypoxiaRight ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT05349630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05349630.